Gene Expression Signatures for Detection of Underlying Philadelphia Chromosome-like (Ph-like) Events and Therapeutic Targeting in Leukemia

摘要

The invention provides arrays, systems, devices, methods, computer-readable media and kits that enable expression-based classification of B-precursor acute lymphoblastic leukemia (ALL) as being either responsive or non-responsive to tyrosine kinase inhibitor mono or co-therapy.